Press release
Chemotherapy Induced Peripheral Neuropathy (CIPN) Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Medici Nova, Asahi Kasei Pharma, AnnJi Pharma, EA Pharma, Aptinyx, Toray, Enveric
"Chemotherapy Induced Peripheral Neuropathy (CIPN) Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Chemotherapy Induced Peripheral Neuropathy Therapeutics Market.
The report provides a detailed description of the Chemotherapy Induced Peripheral Neuropathy drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Chemotherapy Induced Peripheral Neuropathy Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/chemotherapy-induced-peripheral-neuropathy-cipn-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Chemotherapy Induced Peripheral Neuropathy (CIPN) Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Chemotherapy Induced Peripheral Neuropathy therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Chemotherapy Induced Peripheral Neuropathy treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Chemotherapy Induced Peripheral Neuropathy drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Chemotherapy Induced Peripheral Neuropathy treatment market.
Learn More about the Clinical and Commercial Development Activities in the Chemotherapy Induced Peripheral Neuropathy Therapeutics Domain @
https://www.delveinsight.com/report-store/chemotherapy-induced-peripheral-neuropathy-cipn-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Chemotherapy Induced Peripheral Neuropathy (CIPN) Therapeutics Analysis
There are approx. 13+ key companies developing therapies for Chemotherapy Induced Peripheral Neuropathy (CIPN). Currently, MediciNova is leading the therapeutics market with its Chemotherapy Induced Peripheral Neuropathy (CIPN) drug candidates in the most advanced stage of clinical development.
Chemotherapy Induced Peripheral Neuropathy (CIPN) Companies in the Therapeutics Market Include:
• Medici Nova
• Asahi Kasei Pharma Corp.
• AnnJi Pharmaceutical
• EA Pharma
• Aptinyx
• Sonnet Biotherapeutics Holdings
• Toray
• Solasia Pharma
• Enveric Biosciences
• Regenacy Pharmaceuticals
• Neuro BoPharmaceuticals
And Many Others
Emerging and Marketed Chemotherapy Induced Peripheral Neuropathy (CIPN) Therapies Covered in the Report Include:
• MN-166 (ibudilast): MediciNova
• ART-123: Asahi Kasei Pharma Corp.
And Many More
Get an in-depth Assessment of the Emerging Therapies and Chemotherapy Induced Peripheral Neuropathy Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/chemotherapy-induced-peripheral-neuropathy-cipn-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Chemotherapy Induced Peripheral Neuropathy Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Chemotherapy Induced Peripheral Neuropathy (CIPN) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Chemotherapy Induced Peripheral Neuropathy Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/chemotherapy-induced-peripheral-neuropathy-cipn-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Chemotherapy Induced Peripheral Neuropathy Current Treatment Patterns
4. Chemotherapy Induced Peripheral Neuropathy - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Chemotherapy Induced Peripheral Neuropathy Late-Stage Products (Phase-III)
7. Chemotherapy Induced Peripheral Neuropathy Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Chemotherapy Induced Peripheral Neuropathy Discontinued Products
13. Chemotherapy Induced Peripheral Neuropathy Product Profiles
14. Chemotherapy Induced Peripheral Neuropathy Companies
15. Chemotherapy Induced Peripheral Neuropathy Drugs
16. Dormant and Discontinued Products
17. Chemotherapy Induced Peripheral Neuropathy Unmet Needs
18. Chemotherapy Induced Peripheral Neuropathy Future Perspectives
19. Chemotherapy Induced Peripheral Neuropathy Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/chemotherapy-induced-peripheral-neuropathy-cipn-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy Induced Peripheral Neuropathy (CIPN) Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Medici Nova, Asahi Kasei Pharma, AnnJi Pharma, EA Pharma, Aptinyx, Toray, Enveric here
News-ID: 3344525 • Views: …
More Releases from DelveInsight Business Research LLP
Erectile Dysfunction Devices Market Outlook Report 2032 by DelveInsight Explorin …
DelveInsight's Erectile Dysfunction Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Erectile Dysfunction Devices Companies market shares, challenges, Erectile Dysfunction Devices Market Drivers, barriers, trends, and key market Erectile Dysfunction Devices companies in the market.
To read more about the latest highlights related to the Erectile Dysfunction Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/erectile-dysfunction-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key…
Structural Heart Devices Market Size Report 2032: DelveInsight Report on Demand …
DelveInsight's Structural Heart Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Structural Heart Devices Companies market shares, challenges, Structural Heart Devices Market Drivers, barriers, trends, and key market Structural Heart Devices companies in the market.
To read more about the latest highlights related to the Structural Heart Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways…
DelveInsight's Urolithiasis Management Devices Market 2032 Report Offering In-De …
DelveInsight's Urolithiasis Management Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Urolithiasis Management Devices Companies market shares, challenges, Urolithiasis Management Devices Market Drivers, barriers, trends, and key market Urolithiasis Management Devices companies in the market.
To read more about the latest highlights related to the Urolithiasis Management Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/urolithiasis-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways…
Transradial Access Products Market Forecast Report 2032 by DelveInsight Featurin …
DelveInsight's Transradial Access Products Market Insights Report 2032 provides the current and forecast market analysis, individual leading Transradial Access Products Companies market shares, challenges, Transradial Access Products Market Drivers, barriers, trends, and key market Transradial Access Products companies in the market.
To read more about the latest highlights related to the Transradial Access Products Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/transradial-access-products-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways…
More Releases for Neuro
Neuro Energizer Review - Does It Really Work? 2025
Neuro Energizer Review - Does It Really Work? 2025
Feeling mentally foggy and lacking energy is common. Millions seek ways to boost their brain power and stay alert. Neuro Energizer is a new supplement that aims to improve mental clarity, focus, memory, and energy.
But does it actually work? Neuro Energizer uses a unique 7-second brain trick to reboot your mind. In this review, we'll look at the science and customer feedback…
Neuro Balance Therapy Reviews- [Canada & USA] Fake Or Light?| Program, Neuro-Bal …
What Is Neuro-Balance Therapy?
Most people do not realize that they have a problem with their balance immediately. They stumble from time to time, but believe that the main reason for these problems is due to the surface on which they walk or their clumsiness. Unfortunately, as these tripping and falling problems become more common, consumers are starting to see an emerging trend, realizing that they are not just going through…
Global Neuro-stimulators Market By Type (Invasive Neuro-stimulators, Non-invasiv …
The Global Neuro-stimulators Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Neuro-stimulators Market report aims to provide an overview of Neuro-stimulators Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Neuro-stimulators Market Economy by Manufacturers, Regions, kind…
Neuro Ablation Devices Market Professional Survey Report 2018
Neuro ablation devices are medical devices that are applied to iatrogenic Peripheral Nerve Injury (PNI). A peripheral nerve is composed of axon, myelin, endoneurium, fascicle, perineurium and epineurium. The individual myelinated axons and groups of unmyelinated axons are usually surrounded by the endoneurium. Currently available neuro ablation devices focus on precise and target-oriented denervation. Recurrence of pain after a short period is always a problem in pain practice. Recurrence of…
Peripheral Nerve Stimulators Market || Key Player - Stim wave LLC, Neuro Sigma I …
Market Research Reports Search Engine (MRRSE) has recently updated its massive report catalogue by adding a fresh study titled “Peripheral Nerve Stimulators Market Industry Development Scenario and Forecast to 2026”. This business intelligence study encapsulates vital details about the market current as well as future status during the mentioned forecast period of 2026.The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated to growth…
Neuro-navigation Systems Market - Size, Share, Outlook
Rising adoption of minimally invasive surgical procedures is expected to fuel growth of the neuro-navigation systems market. Moreover, increasing number of neurological surgeries performed worldwide is also expected to drive demand for neuro-navigation market. According to the AANS National Neurosurgical Procedural Statistics, in 2011, neurosurgeons performed 2,296,331 total procedures, 1,448,400 of which were spine surgeries in the U.S. Rise in number of people suffering with brain tumor and cancer leading…
